In a time when deep tech and biotech innovation is picking up speed across Europe, a small but mighty investor from Ghent is making waves.
Biotope Ventures has just secured the first $5 million towards its second investment fund—and they’re not stopping there.
On Track for a $9 Million Goal
Biotope Ventures is aiming to raise a total of $9 million over the next 18 months.
The freshly raised $5 million represents a strong first close, setting the stage for a broader push to support more early-stage biotech ventures around the world.
Backed by Big Names and Trusted Institutions
The fund has drawn in support from some major players in Belgium’s financial and biotech scenes.
That includes BNP Paribas Fortis, the Agri Investment Fund (AIF), SFPIM Relaunch, Anacura, and biotope’s parent institution, the Flemish Biotechnology Institute (VIB).
It also attracted funding from family offices like The Nest and Edaphon.
Investing €250K in the Brightest Early-Stage Biotech Ideas
With this new fund, Biotope plans to invest €250,000 in as many as 30 early-stage biotech startups.
But it’s not just about the money—selected startups will also get hands-on support to refine their technology, strengthen their IP and regulatory strategies, and prepare to pitch to future investors.
A Unique Selection and Support Process
Twice a year, Biotope selects three promising biotech startups.
These teams take part in an intensive three-week basecamp where their business case and scientific potential are put under the microscope.
The experience ends with a pitch to Biotope’s Investment Committee. It’s all about getting them investment-ready.
Impressive Results from Fund One
Biotope’s first fund had a strong track record, investing in 16 European biotech startups over three years.
The portfolio spanned food, agriculture, and sustainable materials.
Four of those startups—Zymofix, AmphiStar, B’Zeos, and PFx Biotech—have already gone on to close their seed rounds, and collectively, all 16 have raised €30 million in follow-on funding.
Biotope’s Leaders Are No Strangers to the Industry
The firm is run by a seasoned leadership team. Annick Verween, who heads Biotope by VIB, brings in-depth experience from within the biotech research world.
Managing Director Jérôme Van Biervliet also plays a key role in guiding the fund’s direction and investment strategy.
What’s Next?
With half the target raised and a proven support model in place, Biotope Ventures looks poised to continue nurturing Europe’s next generation of biotech innovators.
The next 18 months will be crucial as they work towards their final fundraising goal and continue scouting for the most promising biotech talent across borders.